Canandaigua National Bank & Trust’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-1,761
Closed -$337K 282
2019
Q4
$337K Buy
+1,761
New +$318K 0.06% 206
2016
Q4
Sell
-1,076
Closed -$248K 205
2016
Q3
$248K Sell
1,076
-42
-4% -$10.3K 0.07% 171
2016
Q2
$258K Sell
1,118
-709
-39% -$163K 0.07% 165
2016
Q1
$490K Sell
1,827
-2,607
-59% -$746K 0.14% 127
2015
Q4
$1.39M Sell
4,434
-32
-0.7% -$9.53K 0.42% 66
2015
Q3
$1.21M Buy
+4,466
New +$1.37M 0.39% 76

Other funds holding AGN

Canandaigua National Bank & Trust's AGN Position: Q1 2020 in Review

Canandaigua National Bank & Trust sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 1,761 shares — an estimated $337K sold.

Canandaigua National Bank & Trust first reported a position in AGN in Q3 2015 and held it in 6 quarters. The position peaked at $1.39M in Q4 2015. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

  • Canandaigua National Bank & Trust reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
  • Canandaigua National Bank & Trust sold 1,761 Allergan plc shares in Q1 2020, an estimated $337K.
  • Canandaigua National Bank & Trust first reported a position in Allergan plc in Q3 2015 and held it in 6 quarters.
  • Canandaigua National Bank & Trust's Allergan plc position peaked at $1.39M in Q4 2015.
  • 876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on Canandaigua National Bank & Trust's 13F filing for Q1 2020, filed 16 Apr 2020.